Anticonvulsants Flashcards

1
Q

Partial vs Generalized seizure

A

Partial - focal/ localised onset, where they [can be] still aware (or not)
Generalised - affecting both hemispheres, with characteristic features of:
- Absence (lapse of awareness)
- Myoclonic (sudden massive jerk - Upper limbs > )
- Atonic
- Tonic - clonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Seizure

A

Clinical manifestation of an abn & excessive paroxysmal discharge of cerebral neurones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define Epilepsy

A

Chronic condition with recurrent, unprovoked seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 goals of anticonvulsant therapy:

A

1 - seizure free/ significant reduction in seizures
2 - Minimize drug effects
3 - Maintain/ restore QoL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Requirements to start AC therapy at first seizure

A
  • Structural brain lesion
  • Abnormal neuro exam
  • Status epilepticus at presentation
  • Strong family Hx
  • Epileptiform abnormal on EEG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which Anti-convulsant drug has the best side effects profile and is most effective

A

HAH! TRICK QUESTION! (sorry liv). NO single ACD is most effective / best tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How to select ACD

A

o Type of seizure
o Potential for drug interaction
o Comorbid disease / SE profile
o Pregnancy risk
o Cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you go about initiating ACD in terms of dosage

A

Start low and increase gradually to build a therapeutic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many different agents should be used:

A

MONOTHERAPY IS THE GOAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If trial of one drug is failing what are you next steps:

A

check adherence, drug concentration at therapeutic range – if no cause found then gradually withdraw – try another monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Problems with multimodal AC therapy (multiple drugs)

A

higher toxicity risk
interaction
jeopardises adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When to stop ACT

A

Consider if seizure free >2 yrs - Especially if normal EEG, no structural lesion, normal intelligence
Taper off very slowly (3/12)
Patient must understand risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 main mechanisms of actions of anticonvulsants:

A

1 - Reduce high frequency neuronal firing by modifying neurotransmitter activity [ie. benzos; valproate]
o Increase GABA activity
o Reduce excitatory glutamate
2- Modify activity of ion channels [ie. carba.; phenytoin etc.]
o Voltage gate Na channels
o Ca channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why therapeutic drug monitoring is important in epilepsy

A

High variability in PK/PD (efficacy and toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When to start therapeutic drug monitoring

A

Poor seizure control
Features of toxicity
Possible interacting drug co-administered
Assess adherence
Guide dose adjustments when interacting drug added to or removed from regimen or during pregnancy
NOT if seizures well controlled & no toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to do therapeutic drug monitoring

A

Wait until steady state achieved (4-5 half lives) before starting monitoring
Therapeutic range = guide only
Dose determination depends on ind response & adverse effects
Most have narrow therapeutic index

17
Q

What is status epilepticus

A

A seizure or cluster of seizures lasting 30 minutes > without intervening periods of consciousness. It is a medical emergency because death and permanent brain damage risk increase with length of attack.

18
Q

Management of status epilepticus

A

1 - abort the seizure - IV benzo [Lora/dia/clonazepam], if no IV access can use buccal or IM [lorazepam/clonazepam only], or PR [diazepam]
2 - Airway maintenance after seizure aborted
3 - Prevent further seizures - IV infusion phenytoin loading dose followed by maintenance doses (phenobarb preferred in children)

19
Q

If you cannot control seizures in S.Epilepticus

A

Intubate and Thiopental/Propofol

19
Q

If you cannot control seizures in S.Epilepticus

A

Intubate and Thiopental/Propofol infusion

20
Q

Anticonvulsants in pregnancy

A

AVOID Sodium valproate, Carbamazepine is lowest risk
* Folate supplementation essential- preferably before conception
* Pregnancy reduces drug levels in 2nd and 3rd trimesters, adjust dose according to levels

21
Q

BONUSSSSS - Drugs possible for … type of seizures:
1 - Tonic-clonic
2- Absence
3- Myoclonic
4- Focal seizures

A

Tonic-clonic: Carb; Phenytoin; Phenobarbital; Lamotrigine; Valproate
Absence: Ethosuximide; Valproate; (Lamotrigine – off label) +++
Myoclonic: Clonazepam; Valproate
Focal seizures: Carb; Gabapentin; Phenytoin; Phenobarbital; Lamotrigine; Valproate; +++

22
Q

Phenobarbital (barbiturate)
Indications
MOA
PK
CI’s

A

Indications: Epilepsy except for absence or myoclonic; Status epilepticus
MOA: GABA receptor mediation
PK: Good oral bioavailibility (70%-90%), Metab. in liver, Excreted in urine, steady state in 10-16 days
CI’s: Severe hepatic/renal impairment, Porphyria

23
Q

Phenobarbital (barbiturate)
Cautions
Adverse effects
Drug Interactions

A

Cautions: DM, Hyperthy., asthma (other resp. diseases), geriatric things (confusion, depression), pregnancy (not safe but risks < seizures)
Adverse effects: drowsiness (decreases over time), CNS (ataxia, nystag., dizzy), derm (hypersens. and photosensitivity), Vitamin D def., withdrawal and dependence
Drug Interactions: Induces!!!!! hepatic microsomal enzymes therefore Hepatic metab. agents [warfarin, COCs, Corticosteroids, tetracyclines, digoxin, beta blockers]; ARVs (reduces levels);

24
Q

Phenytoin
Indications
MOA
PK
CI’s

A

Indications: Epilepsy except absence or myoclonic , Status epilepticus
MOA: Prolongs inactivation of voltage sensitive Na Channels
PK: variable oral bioavail.; protein bound; Metab. in liver but it is saturable [inc. doses small]; renal excretion; steady in 5-10 days
CI’s: Impaired cardiac func, Porphyria

25
Q

Phenytoin
Cautions
Adverse effects
Drug Interactions

A

Cautions: liv and hep. compromise; Preg. [not safe have to give folic acid and prophylactic vit. K to mother as well as monitor freq.]
Adverse effects: CVS arrythmias; CNS cerebellar Sx, skin rashes

NB: gum hypertrophy, hirsuitism, decreased bone density, folic acid depletion

problems associated: strong inducer of CYP and UGT, reduces effectiveness of most forms of hormonal contraceptives

26
Q

Phenytoin drug interactions

A

↑ phenytoin levels:
Acute alcohol intake
Fluconazole
Fluoxetine
Isoniazid
Diazepam

↓ phenytoin levels
Chronic alcohol abuse
Folic acid
Rifampicin
Theophylline
Ca supplements & antacids (reduced absorption, take 1-3h apart)

Other anti-epileptics: unpredictable, must be monitored
Lamotrigine: induced lam met
ARVS: avoid concurrent use
Lithium: toxicity sx but normal range
COCs
Warfarin: change to anticoag efficacy

27
Q

Carbamazepine
Indications
Mechanism
PK
CI’s
Adverse effects
Drug interactions

A

Indications: Epilepsy except absence or myoclonic or atonic, Management of pain esp neuralgia
Mechanism: Prolongs inactivation of voltage sensitive Na Channels and potentiates postsynaptic actions of GABA
PK: Slow and variable absorp.; enhanced with food; metab. by liver exc. renal; AUTOINDUCTION
CI’s: AV block, porphyria
Adverse Effects - Drowsiness, vertigo, ataxia, diplopia and blurred vision
Heamatological toxicity – aplastic anaemia, agranulocytosis; Hypersensitivity
Extra: before initiation: FBC, renal & LFTS before
Monitor serum Na (SIADH)
Take with food

28
Q

Valproate
Indications
Drug interactions
Mechanism
Adverse effects

A

AVOID IN WOMAN OF CHILDBEARING AGE

29
Q

what is the metabolism of phenytoin

A

saturable, zero-order
increased dose means plasma conc rises exponentially (not linearly)

30
Q

Why is phenytoin monitoring a bit tricky?

A

Highly protein-bound
narrow therapeutic window
nonlinear PK